Brentuximab Biosimilar - Anti-CD30 Antibody - BSA and Azide free
Descrizione
Recombinant chimeric monoclonal antibody to CD30.
Applicazioni
ELISA
Diluizioni consigliate
ELISA: 1:5,000-10,000
Reattività
Human
Specie ospite
Chimeric
Clonalità
Monoclonal
Isotipo
IgG1
Coniugare
Unconjugated
Purificazione
Affinity chromatography.
Concentrazione
Reconstitution dependent.
Forma del prodotto
Lyophilized
Ricostituzione
Reconstitute with distilled sterile water.
Formulazione
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Conservazione
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Note generali
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
Sinonimi
CD 30, CD30 antigen, CD30L receptor, Cytokine receptor CD30, D1S166E, KI 1, KI 1 antigen, Ki-1 antigen, KI1, Lymphocyte activation antigen CD30, TNFRSF 8, Tnfrsf8, TNR8_HUMAN, Tumor necrosis factor receptor superfamily member 8
Dichiarazione di non responsabilità
Questo prodotto è solo per uso di ricerca. Non è inteso per uso diagnostico o terapeutico.
ELISA plate pre-coated by 2 µg/ml (100 µl/well) Recombinant Human CD30 Protein (6xHis Tag) (A318247) can bind Anti-CD30 Chimeric Antibody [Brentuximab Biosimilar] - Azide free (A318939) in a linear range of 0.13-80 µg/ml.
Prodotti alternativi a Anti-CD30 Anticorpo (A318939)